Borrello v. Respironics California, LLC (P)

CourtDistrict Court, S.D. California
DecidedSeptember 14, 2023
Docket3:23-cv-00580
StatusUnknown

This text of Borrello v. Respironics California, LLC (P) (Borrello v. Respironics California, LLC (P)) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Borrello v. Respironics California, LLC (P), (S.D. Cal. 2023).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 MIKE BORRELLO, Case No.: 23-cv-580-GPC-WVG

12 Plaintiff, ORDER 13 v. (1) GRANTING MOTION TO DISMISS PLAINTIFF’S 14 RESPIRONICS CALIFORNIA, LLC; COMPLAINT RESPIRONICS NOVAMETRIX, LLC; 15 [ECF No. 5] PHILIPS NORTH AMERICA LLC; (2) DENYING PLAINTIFF’S 16 PHILIPS RS NORTH AMERICA LLC; REQUEST FOR JUDICIAL NOTICE PHILIPS DS NORTH AMERICA LLC; 17 [ECF No. 15] PHILIPS HOLDING USA INC.; VITOR 18 ROCHA, 19 Defendants. 20 21 Currently pending before the Court is a motion to dismiss, ECF No. 5, Plaintiff Mike 22 Borrello’s Complaint, ECF No. 1-2 at 5 (“Compl.”). Defendants Respironics California, 23 LLC; Respironics Novametrix, LLC; Philips North America LLC; Philips RS North 24 America LLC; Philips DS North America LLC; Philips Holding USA Inc; and Vitor Rocha 25 (collectively “Defendants”) move to dismiss the Complaint in its entirety for failure to state 26 a claim upon which relief can be granted under Federal Rule of Civil Procedure 12(b)(6). 27 1 ECF No. 5. Borrello has responded, ECF No. 13, and Defendants filed a reply, ECF No. 2 14. 3 Pursuant to Civil Local Rule 7.1.d, the Court determined the matter was ripe for 4 decision without oral argument and vacated the hearing that was scheduled for 5 May 26, 2023. ECF No. 18. For the reasons that follow, Defendants’ Motion to Dismiss 6 is hereby GRANTED and limited leave to amend the Complaint is GRANTED. 7 I. FACTUAL AND PROCEDURAL BACKGROUND 8 A. Borrello’s Employment With Respironics 9 In December 2012, Plaintiff Mike Borrello accepted an at-will employment offer 10 from Defendant Respironics California, LLC, ECF No. 1-2 at 291 (Compl. ¶ 29); id. at 63– 11 64; see ECF No. 5-1 at 8, a subsidiary of Philips, ECF No. 1-2 at 6. Borrello started 12 working at Respironics California in January 2013. ECF No. 1-2 at 10, 11 (Compl. ¶ 11, 13 18); ECF No. 5-1 at 8. 14 Borrello alleges that the Philips North America Severance Plan, see ECF No. 1-2 15 at 80, constituted part of the “company policy manual (aka employee handbook).” Id. at 16 13 (Compl. ¶¶ 30–31). The Severance Plan, attached to the Complaint,2 explains that 17 Philips North America LLC has “sole discretion” to determine, in relevant parts, employee 18 eligibility for severance benefits; the terms and conditions for receiving such benefits; and 19 whether the terms and conditions have been satisfied. Id. at 82. “Employees who 20 voluntarily resign” are ineligible for severance benefits under the Severance Plan. Id. 21 22 23 24 1 Page numbers are based on the CM/ECF pagination. 25 2 Borrello appears to have attached a summary of the plan, not the “legal plan document.” 26 See ECF No. 1-2 at 80. For purposes of this Order, the Court will refer to the plan summary as the Severance Plan. 27 1 B. Respironics’/Philips’ New Vaccine Policy 2 Borrello’s employment ended shortly after Philips3 implemented a mandatory new 3 vaccine policy. On October 27 2021, Philips emailed a “COVID-19 Update” to its North 4 American employees. ECF No. 1-2 at 15 (Compl. ¶ 46); ECF No. 5-1 at 8–9; see ECF No. 5 1-2 at 69–70 (email). The email was signed by the Philips CEO as well as the Chief Market 6 Leader, Defendant Vitor Rocha. ECF No. 1-2 at 70. The email instructed that “[e]ffective 7 December 8, 2021, employees based in the U.S. are required to be vaccinated against 8 COVID, as a condition of employment at Philips.” Id. at 69. It instructed that employees 9 were required to “provide proof of vaccination by January 10, 2022, or have requested and 10 qualified for a reasonable accommodation.” Id. Otherwise, the employees would “be 11 considered a voluntary quit on February 4, 2022.” Id. The email also explained that this 12 policy change was due to (1) high infection and hospitalization rates in the United States; 13 and (2) a federal “mandate for all federal workers to be vaccinated against COVID, which 14 extends to federal contractors like Philips.”4 Id. 15 Borrello received another email from Philips on November 8 which gave more 16 specific information about the new COVID-19 vaccination policy. ECF No. 1-2 at 24 17 (Compl. ¶ 96-97); ECF No. 1-2 at 66–67. The email instructed that all “U.S.-based 18

19 3 “Philips” is used generally throughout the Complaint and the attached exhibits. It does 20 not appear to apply to any particular Defendant but rather the overall corporate entity. The 21 Court similarly uses “Philips” generally in this Order. 22 4 Borrello alleges that by January 26, 2022 this federal vaccine mandate was no longer in effect, but Philips did not change its own vaccine mandate policy. ECF No. 1-2 at 27 23 (Compl. ¶ 111). However, January 26 is of course 16 days after Philips’ January 10 24 deadline. And even though the Supreme Court of the United States stayed the implementation of the mandate on January 13, 2022, see Nat’l Fed’n of Indep. Bus. v. Dep’t 25 of Lab., OSHA, 142 S. Ct. 661 (2022), this was still 3 days after Philips’ January 10 26 deadline. Borrello acknowledges that Defendants did not “change its own vaccine mandate policy to align with the court decision.” ECF No. 1-2 at 27 (Compl. ¶ 111). 27 1 employees” were required to become fully vaccinated against COVID-19 by 2 January 4, 2022 and must “[u]pload proof of vaccination, or reasonable accommodation 3 qualification [to a Human Resources portal (“HR Portal”)] by January 10, 2022.” ECF 4 No. 1-2 at 66. The email explained that employees who failed to “upload[] the required 5 documentation by January 10, 2022, or request[] and qualif[y] for a reasonable 6 accommodation, [would] be considered out of compliance and [would] have 25 days to 7 return to compliance.” Id. The email stated that any employees that had not complied 8 would “be considered a voluntary quit on February 4, 2022.” Id. The email included a 9 link to a Frequently Asked Questions (“FAQ”) page about the new COVID-19 policy and 10 instructed employees to contact their “Human Resources manager with additional 11 questions.” Id. at 66–67. 12 The FAQ page addressed much of the information already disclosed via email in 13 greater detail. ECF No. 1-2 at 73–78. In relevant parts, the FAQ page explained that 14 “[e]mployees with a sincerely held religious belief and/or disability impacting their ability 15 to obtain the COVID vaccine should request a reasonable accommodation via the HR 16 Portal.” Id. at 73 (“via the HR portal” was underlined and appears to have been 17 hyperlinked). It also explained that this vaccine policy applied, as a condition of 18 employment, “to all U.S.-based Philips employees,” even those who worked remotely. Id. 19 at 74. The last section of the FAQ page was titled “Reasonable Accommodation” which 20 encouraged employees to consult with their physician about any “questions or concerns 21 about risk, allergic dispositions, pregnancy or other medical situations.” Id. at 77 22 (capitalization removed). It explained that “[t]he reasonable accommodation process is an 23 interactive dialogue between employee, direct manager and Human Resources.” Id. 24 On January 6 and 10, 2022, Borrello received nearly identical emails reminding him 25 about the policy requiring that he upload documents showing that he is fully vaccinated or 26 requesting a reasonable accommodation by January 10. ECF No. 1-2 at 26–27 (Compl. ¶¶ 27 1 107, 110); id. at 102–03 (January 6 email); id. at 106–07 (January 10 email). The emails 2 explained how employees “requiring a medical disability or religious exemption” could 3 submit a request for a reasonable accommodation. Id. at 102, 106.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
United States v. Seeger
380 U.S. 163 (Supreme Court, 1965)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Bryan v. MacPherson
630 F.3d 805 (Ninth Circuit, 2010)
Ivey v. Board of Regents of University of Alaska
673 F.2d 266 (Second Circuit, 1982)
John Desoto v. Yellow Freight Systems, Inc.
957 F.2d 655 (Ninth Circuit, 1992)
Hill v. National Collegiate Athletic Assn.
865 P.2d 633 (California Supreme Court, 1994)
Bily v. Arthur Young & Co.
834 P.2d 745 (California Supreme Court, 1992)
Intri-Plex Technologies, Inc. v. Crest Group, Inc.
499 F.3d 1048 (Ninth Circuit, 2007)
Moss v. U.S. Secret Service
572 F.3d 962 (Ninth Circuit, 2009)
American Savings v. Bell
562 F. Supp. 4 (District of Columbia, 1981)
ELSENBERG v. Alameda Newspapers, Inc.
88 Cal. Rptr. 2d 802 (California Court of Appeal, 1999)
Smith v. Superior Court
10 Cal. App. 4th 1033 (California Court of Appeal, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
Borrello v. Respironics California, LLC (P), Counsel Stack Legal Research, https://law.counselstack.com/opinion/borrello-v-respironics-california-llc-p-casd-2023.